CIK 0001682852
- Large accelerated filer
Moderna, Inc.
Sign in to watch- Ticker
- MRNA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813467528
- Phone
- +1 617-714-6500
- Business address
- 325 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- Moderna Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $50,775,837
- in 5 filings, $50.8M under 10b5-1 plans
Net −$50,775,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-10-04 | AFEYAN NOUBAR Director | Sale 10b5-1 | −2,700 | $102.03 | $275K | 2,191,401 |
| 2023-10-04 | AFEYAN NOUBAR Director | Sale 10b5-1 | −5,604 | $103.22 | $578K | 2,185,797 |
| 2023-10-04 | AFEYAN NOUBAR Director | Sale 10b5-1 | −3,866 | $104.04 | $402K | 2,181,931 |
Page 38 of 38 · 743 trades